Ladislav Volicer.

In addition, this research underscores the need to improve the quality of palliative treatment in assisted living facilities in order to reduce the physical suffering of citizens with advanced dementia who are dying.. Susan L. Mitchell, M.D., M.P.H., Joan M. Teno, M.D., Dan K. Kiely, M.P.H., Michele L. Shaffer, Ph.D., Richard N. Jones, Sc.D., Holly G. Prigerson, Ph.D., Ladislav Volicer, M.D., Ph.D., Jane L. Givens, M.D., M.S.C.E., and Mary Beth Hamel, M.D., M.P.H.: The Clinical Course of Advanced Dementia A growing number of Americans are dying with dementia.1 Prior function suggests that sufferers with advanced dementia are under-recognized as being at high risk for loss of life and receive suboptimal palliative caution.2-4 Having less information characterizing the final stage of dementia might impede the quality of care provided to these sufferers.Our study provides strong preliminary evidence that reduced-intensity chemoradiotherapy could be as effective as standard-dose chemoradiotherapy, business lead study writer Dr. Bhishamjit Chera, associate professor of radiation oncology at University of North Carolina School of Medicine, said in a society news release. With an increase of study, Chera said, the routine could become standard look after carefully selected patients with HPV-associated squamous cell carcinoma of the tonsils and tongue.